No Prescription |
 |
 | ||
|
Foradil Foradile |
|
| ||
No Prescription » Prescription Drugs 8 » Foradil Foradile Medical Information:Foradil relaxes the muscles in the walls of the airways allowing them to expand. Taken on a twice-daily basis it helps to control asthma in people who need regular treatment with short-acting inhalers including people with nighttime asthma. Regular twice-daily use can also relieve tightening of the airways in people with Chronic Obstructive Pulmonary Disease including chronic bronchitis and emphysema.Taken on an as-needed basis Foradil can also be used to prevent exercise-induced tightening of the airways (also called "exercise-induced asthma") in adults and children 12 years of age and older.Formoterol is a long-acting bronchodilator that relaxes muscles in the airways to improve breathing.Formoterol inhalation is used to prevent bronchospasm in people with reversible obstructive airways disease including symptoms of night-time asthma. It is also used in people with chronic obstructive pulmonary disease (COPD) such as emphysema and chronic bronchitis.Long-term treatment of asthma. It may be used to prevent breathing problems in certain patients including patients with nighttime asthma or breathing problems caused by exercise. It may be used for long-term treatment of chronic obstructive pulmonary disease (COPD). It may also be used for other conditions as determined by your doctor.Foradil Aerolizer is a long-acting beta-agonist bronchodilator. It widens the airways in the lungs which helps you breathe more easily. Buy Foradil Foradile and other Prescription Drugs 8 products online at Medstore. 3603
About Foradil Foradile: Product Type: Prescription Drugs 8 Foradil ( Foradile Generic Eformoterol Fumarate Dehydrate ) Foradil (Foradile Generic Eformoterol Fumarate Dehydrate) Foradile Generic Eformoterol Fumarate Dehydrate 12mcg Inhalation Cap 60 Capsules Foradile Generic Eformoterol Fumarate Dehydrate Foradil
View more Prescription Drugs 8 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
